Cargando…

Downregulation of extramitochondrial BCKDH and its uncoupling from AMP deaminase in type 2 diabetic OLETF rat hearts

Systemic branched‐chain amino acid (BCAA) metabolism is dysregulated in cardiometabolic diseases. We previously demonstrated that upregulated AMP deaminase 3 (AMPD3) impairs cardiac energetics in a rat model of obese type 2 diabetes, Otsuka Long‐Evans‐Tokushima fatty (OLETF). Here, we hypothesized t...

Descripción completa

Detalles Bibliográficos
Autores principales: Ogawa, Toshifumi, Kouzu, Hidemichi, Osanami, Arata, Tatekoshi, Yuki, Sato, Tatsuya, Kuno, Atsushi, Fujita, Yugo, Ino, Shoya, Shimizu, Masaki, Toda, Yuki, Ohwada, Wataru, Yano, Toshiyuki, Tanno, Masaya, Miki, Takayuki, Miura, Tetsuji
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9938007/
https://www.ncbi.nlm.nih.gov/pubmed/36802195
http://dx.doi.org/10.14814/phy2.15608
_version_ 1784890546409439232
author Ogawa, Toshifumi
Kouzu, Hidemichi
Osanami, Arata
Tatekoshi, Yuki
Sato, Tatsuya
Kuno, Atsushi
Fujita, Yugo
Ino, Shoya
Shimizu, Masaki
Toda, Yuki
Ohwada, Wataru
Yano, Toshiyuki
Tanno, Masaya
Miki, Takayuki
Miura, Tetsuji
author_facet Ogawa, Toshifumi
Kouzu, Hidemichi
Osanami, Arata
Tatekoshi, Yuki
Sato, Tatsuya
Kuno, Atsushi
Fujita, Yugo
Ino, Shoya
Shimizu, Masaki
Toda, Yuki
Ohwada, Wataru
Yano, Toshiyuki
Tanno, Masaya
Miki, Takayuki
Miura, Tetsuji
author_sort Ogawa, Toshifumi
collection PubMed
description Systemic branched‐chain amino acid (BCAA) metabolism is dysregulated in cardiometabolic diseases. We previously demonstrated that upregulated AMP deaminase 3 (AMPD3) impairs cardiac energetics in a rat model of obese type 2 diabetes, Otsuka Long‐Evans‐Tokushima fatty (OLETF). Here, we hypothesized that the cardiac BCAA levels and the activity of branched‐chain α‐keto acid dehydrogenase (BCKDH), a rate‐limiting enzyme in BCAA metabolism, are altered by type 2 diabetes (T2DM), and that upregulated AMPD3 expression is involved in the alteration. Performing proteomic analysis combined with immunoblotting, we discovered that BCKDH localizes not only to mitochondria but also to the endoplasmic reticulum (ER), where it interacts with AMPD3. Knocking down AMPD3 in neonatal rat cardiomyocytes (NRCMs) increased BCKDH activity, suggesting that AMPD3 negatively regulates BCKDH. Compared with control rats (Long‐Evans Tokushima Otsuka [LETO] rats), OLETF rats exhibited 49% higher cardiac BCAA levels and 49% lower BCKDH activity. In the cardiac ER of the OLETF rats, BCKDH‐E1α subunit expression was downregulated, while AMPD3 expression was upregulated, resulting in an 80% lower AMPD3‐E1α interaction compared to LETO rats. Knocking down E1α expression in NRCMs upregulated AMPD3 expression and recapitulated the imbalanced AMPD3‐BCKDH expressions observed in OLETF rat hearts. E1α knockdown in NRCMs inhibited glucose oxidation in response to insulin, palmitate oxidation, and lipid droplet biogenesis under oleate loading. Collectively, these data revealed previously unrecognized extramitochondrial localization of BCKDH in the heart and its reciprocal regulation with AMPD3 and imbalanced AMPD3‐BCKDH interactions in OLETF. Downregulation of BCKDH in cardiomyocytes induced profound metabolic changes that are observed in OLETF hearts, providing insight into mechanisms contributing to the development of diabetic cardiomyopathy.
format Online
Article
Text
id pubmed-9938007
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-99380072023-02-19 Downregulation of extramitochondrial BCKDH and its uncoupling from AMP deaminase in type 2 diabetic OLETF rat hearts Ogawa, Toshifumi Kouzu, Hidemichi Osanami, Arata Tatekoshi, Yuki Sato, Tatsuya Kuno, Atsushi Fujita, Yugo Ino, Shoya Shimizu, Masaki Toda, Yuki Ohwada, Wataru Yano, Toshiyuki Tanno, Masaya Miki, Takayuki Miura, Tetsuji Physiol Rep Original Articles Systemic branched‐chain amino acid (BCAA) metabolism is dysregulated in cardiometabolic diseases. We previously demonstrated that upregulated AMP deaminase 3 (AMPD3) impairs cardiac energetics in a rat model of obese type 2 diabetes, Otsuka Long‐Evans‐Tokushima fatty (OLETF). Here, we hypothesized that the cardiac BCAA levels and the activity of branched‐chain α‐keto acid dehydrogenase (BCKDH), a rate‐limiting enzyme in BCAA metabolism, are altered by type 2 diabetes (T2DM), and that upregulated AMPD3 expression is involved in the alteration. Performing proteomic analysis combined with immunoblotting, we discovered that BCKDH localizes not only to mitochondria but also to the endoplasmic reticulum (ER), where it interacts with AMPD3. Knocking down AMPD3 in neonatal rat cardiomyocytes (NRCMs) increased BCKDH activity, suggesting that AMPD3 negatively regulates BCKDH. Compared with control rats (Long‐Evans Tokushima Otsuka [LETO] rats), OLETF rats exhibited 49% higher cardiac BCAA levels and 49% lower BCKDH activity. In the cardiac ER of the OLETF rats, BCKDH‐E1α subunit expression was downregulated, while AMPD3 expression was upregulated, resulting in an 80% lower AMPD3‐E1α interaction compared to LETO rats. Knocking down E1α expression in NRCMs upregulated AMPD3 expression and recapitulated the imbalanced AMPD3‐BCKDH expressions observed in OLETF rat hearts. E1α knockdown in NRCMs inhibited glucose oxidation in response to insulin, palmitate oxidation, and lipid droplet biogenesis under oleate loading. Collectively, these data revealed previously unrecognized extramitochondrial localization of BCKDH in the heart and its reciprocal regulation with AMPD3 and imbalanced AMPD3‐BCKDH interactions in OLETF. Downregulation of BCKDH in cardiomyocytes induced profound metabolic changes that are observed in OLETF hearts, providing insight into mechanisms contributing to the development of diabetic cardiomyopathy. John Wiley and Sons Inc. 2023-02-17 /pmc/articles/PMC9938007/ /pubmed/36802195 http://dx.doi.org/10.14814/phy2.15608 Text en © 2023 The Authors. Physiological Reports published by Wiley Periodicals LLC on behalf of The Physiological Society and the American Physiological Society. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Articles
Ogawa, Toshifumi
Kouzu, Hidemichi
Osanami, Arata
Tatekoshi, Yuki
Sato, Tatsuya
Kuno, Atsushi
Fujita, Yugo
Ino, Shoya
Shimizu, Masaki
Toda, Yuki
Ohwada, Wataru
Yano, Toshiyuki
Tanno, Masaya
Miki, Takayuki
Miura, Tetsuji
Downregulation of extramitochondrial BCKDH and its uncoupling from AMP deaminase in type 2 diabetic OLETF rat hearts
title Downregulation of extramitochondrial BCKDH and its uncoupling from AMP deaminase in type 2 diabetic OLETF rat hearts
title_full Downregulation of extramitochondrial BCKDH and its uncoupling from AMP deaminase in type 2 diabetic OLETF rat hearts
title_fullStr Downregulation of extramitochondrial BCKDH and its uncoupling from AMP deaminase in type 2 diabetic OLETF rat hearts
title_full_unstemmed Downregulation of extramitochondrial BCKDH and its uncoupling from AMP deaminase in type 2 diabetic OLETF rat hearts
title_short Downregulation of extramitochondrial BCKDH and its uncoupling from AMP deaminase in type 2 diabetic OLETF rat hearts
title_sort downregulation of extramitochondrial bckdh and its uncoupling from amp deaminase in type 2 diabetic oletf rat hearts
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9938007/
https://www.ncbi.nlm.nih.gov/pubmed/36802195
http://dx.doi.org/10.14814/phy2.15608
work_keys_str_mv AT ogawatoshifumi downregulationofextramitochondrialbckdhanditsuncouplingfromampdeaminaseintype2diabeticoletfrathearts
AT kouzuhidemichi downregulationofextramitochondrialbckdhanditsuncouplingfromampdeaminaseintype2diabeticoletfrathearts
AT osanamiarata downregulationofextramitochondrialbckdhanditsuncouplingfromampdeaminaseintype2diabeticoletfrathearts
AT tatekoshiyuki downregulationofextramitochondrialbckdhanditsuncouplingfromampdeaminaseintype2diabeticoletfrathearts
AT satotatsuya downregulationofextramitochondrialbckdhanditsuncouplingfromampdeaminaseintype2diabeticoletfrathearts
AT kunoatsushi downregulationofextramitochondrialbckdhanditsuncouplingfromampdeaminaseintype2diabeticoletfrathearts
AT fujitayugo downregulationofextramitochondrialbckdhanditsuncouplingfromampdeaminaseintype2diabeticoletfrathearts
AT inoshoya downregulationofextramitochondrialbckdhanditsuncouplingfromampdeaminaseintype2diabeticoletfrathearts
AT shimizumasaki downregulationofextramitochondrialbckdhanditsuncouplingfromampdeaminaseintype2diabeticoletfrathearts
AT todayuki downregulationofextramitochondrialbckdhanditsuncouplingfromampdeaminaseintype2diabeticoletfrathearts
AT ohwadawataru downregulationofextramitochondrialbckdhanditsuncouplingfromampdeaminaseintype2diabeticoletfrathearts
AT yanotoshiyuki downregulationofextramitochondrialbckdhanditsuncouplingfromampdeaminaseintype2diabeticoletfrathearts
AT tannomasaya downregulationofextramitochondrialbckdhanditsuncouplingfromampdeaminaseintype2diabeticoletfrathearts
AT mikitakayuki downregulationofextramitochondrialbckdhanditsuncouplingfromampdeaminaseintype2diabeticoletfrathearts
AT miuratetsuji downregulationofextramitochondrialbckdhanditsuncouplingfromampdeaminaseintype2diabeticoletfrathearts